Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)N. Costedoat‐Chalumeau, Alain Dupuy, L. Sailler et al.|Annals of the Rheumatic Diseases|2012Cited by 207
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus ErythematosusM. Jallouli, Lionel Galicier, Noël Zahr et al.|Arthritis & Rheumatology|2015Cited by 140
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adultsM.L. Piel-Julian, L. Prudhomme, Matthieu Mahévas et al.|Journal of Thrombosis and Haemostasis|2018Cited by 138
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndromeAurélien Delluc, P. Cacoub, Nicolas Limal et al.|Annals of the Rheumatic Diseases|2008Cited by 69
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 studyG. Martin de Frémont, Antoine Baudet, N. Costedoat‐Chalumeau et al.|The Lancet Rheumatology|2023Cited by 37